US Stock MarketDetailed Quotes
Protalix Biotherapeutics (PLX)
- 2.295
- -0.035-1.50%
Trading Jul 16 12:45 ET
184.91MMarket Cap12.08P/E (TTM)
2.360High2.280Low329.42KVolume2.325Open2.330Prev Close762.83KTurnover0.43%Turnover RatioLossP/E (Static)80.57MShares3.19052wk High2.75P/B177.74MFloat Cap1.41052wk Low--Dividend TTM77.45MShs Float1037.500Historical High--Div Yield TTM3.43%Range %0.700Historical Low2.316Avg Price1Lot Size
PLX Stock Chart
Real-Time
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
PLX Orderflow
Unit: --
PLX Orderflow Trend
IntradayDayWeekMonth
No Data
Protalix Biotherapeutics (PLX) News
Protalix Shareholders Approve Directors, Compensation and Incentive Plan
Protalix Highlights Elfabrio Dosing Approvals and Growth Plans
Protalix Q1 Call: Milestone-Fueled Profit, Bold Targets
Earnings Call Summary | Protalix Biotherapeutics(PLX.US) Q1 2026 Earnings Conference
Protalix Reaffirms $78M-$83M 2026 Revenue Outlook Following $25M Elfabrio Milestone
CORRECTION: Protalix BioTherapeutics Q1 EPS $0.22 Beats $0.06 Estimate, Sales $33.750M Beat $11.468M Estimate